Drugs / A/H5N1 inactivated, split-virion influenza virus
A/H5N1 inactivated, split-virion influenza virus
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00545701 | Oct 2007 → Jun 2008 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | A/H5N1 inactivated, split-virion influenza virus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00545701 ↗ |
| Modality | Vaccine | “A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine” NCT00545701 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular” NCT00545701 ↗ |